Literature DB >> 35177528

Segmental Motion of Cervical Arthroplasty Leads to Decreased Adjacent-Level Degeneration: Analysis of the 7-Year Postoperative Results of a Multicenter Randomized Controlled Trial.

Jeffrey M Spivak1, Jack E Zigler2, Travis Philipp3, Michael Janssen4, Bruce Darden5, Kris Radcliff6.   

Abstract

BACKGROUND: Cervical artificial disc replacement (C-ADR) has become a common and accepted surgical treatment for many patients with cervical disc degeneration/herniation and radiculopathy who have failed nonoperative treatment. Midterm follow-up studies of the original investigational device exemption trials comparing C-ADR to traditional anterior cervical discectomy and fusion (ACDF) have revealed C-ADR patients have less adjacent-level disease and fewer reoperations at 5 to 7 years. The purpose of this study was to examine the relationship of radiographic adjacent-level disease (R-ALD) with the amount of index-level segmental range of motion (ROM) in C-ADR patients using the long-term follow-up data from the ProDisc-C investigational device exemption trial.
METHODS: This was a post hoc analysis of a 1:1 randomized controlled trial. The initial previously described Food and Drug Administration-approved 2-year study was extended, and consenting patients in the original study were followed at annual intervals up to 7 years. Logistic regression was used to assess any progression in adjacent-level disease (ALD). Ordinal logistic regression was also used to assess the relationship between any progressive R-ALD and final flexion extension (F/E) ROM in C-ADR patients. Spearman's rank-order correlation was used when R-ALD was kept as an ordinal variable to assess the same relationship.
RESULTS: At the last follow-up visit, the rate of progressive R-ALD was significantly higher in ACDF patients than in C-ADR patients. When C-ADR patients were divided into 3 groups based on final F/E ROM, those with 0° to 3° (n = 19), 4° to 6° (n = 15), and 7° (n = 42) of segmental motion at the index procedure level, the rate of progressive R-ALD trended significantly with final ROM (P = 0.01).
CONCLUSIONS: C-ADR leads to a significant decrease in R-ALD compared to ACDF. The difference in R-ALD is related to the preservation of motion at the index level and resultant preservation of kinematics and forces across the adjacent disc space. This manuscript is generously published free of charge by ISASS, the International Society for the Advancement of Spine Surgery.
Copyright © 2022 ISASS. To see more or order reprints or permissions, see http://ijssurgery.com.

Entities:  

Keywords:  adjacent segment degeneration; cervical arthroplasty; disc replacement

Year:  2022        PMID: 35177528      PMCID: PMC9519082          DOI: 10.14444/8187

Source DB:  PubMed          Journal:  Int J Spine Surg        ISSN: 2211-4599


  33 in total

1.  Long-term follow-up after interbody fusion of the cervical spine.

Authors:  Jan Goffin; Eric Geusens; Nicolaas Vantomme; Els Quintens; Yannic Waerzeggers; Bart Depreitere; Frank Van Calenbergh; Johan van Loon
Journal:  J Spinal Disord Tech       Date:  2004-04

2.  Ten-year Outcomes of Cervical Disc Replacement With the BRYAN Cervical Disc: Results From a Prospective, Randomized, Controlled Clinical Trial.

Authors:  William F Lavelle; K Daniel Riew; Allan D Levi; Jeffrey E Florman
Journal:  Spine (Phila Pa 1976)       Date:  2019-05-01       Impact factor: 3.468

Review 3.  A systematic review of randomized trials on the effect of cervical disc arthroplasty on reducing adjacent-level degeneration.

Authors:  Ricardo Vieira Botelho; Osmar José dos Santos Moraes; Gustavo Alberto Fernandes; Yuri dos Santos Buscariolli; Wanderley Marques Bernardo
Journal:  Neurosurg Focus       Date:  2010-06       Impact factor: 4.047

4.  Early results after ProDisc-C cervical disc replacement.

Authors:  Rudolf Bertagnoli; James J Yue; Frank Pfeiffer; Andrea Fenk-Mayer; James P Lawrence; Trace Kershaw; Regina Nanieva
Journal:  J Neurosurg Spine       Date:  2005-04

5.  Artificial disc replacement versus fusion in patients with cervical degenerative disc disease with radiculopathy: 5-year outcomes from the National Swedish Spine Register.

Authors:  Anna MacDowall; Martin Skeppholm; Lars Lindhagen; Yohan Robinson; Håkan Löfgren; Karl Michaëlsson; Claes Olerud
Journal:  J Neurosurg Spine       Date:  2018-11-02

6.  Five-year reoperation rates, cervical total disc replacement versus fusion, results of a prospective randomized clinical trial.

Authors:  Rick B Delamarter; Jack Zigler
Journal:  Spine (Phila Pa 1976)       Date:  2013-04-20       Impact factor: 3.468

7.  Results of the prospective, randomized, controlled multicenter Food and Drug Administration investigational device exemption study of the ProDisc-C total disc replacement versus anterior discectomy and fusion for the treatment of 1-level symptomatic cervical disc disease.

Authors:  Daniel Murrey; Michael Janssen; Rick Delamarter; Jeffrey Goldstein; Jack Zigler; Bobby Tay; Bruce Darden
Journal:  Spine J       Date:  2008-09-06       Impact factor: 4.166

8.  ProDisc-C Total Disc Replacement Versus Anterior Cervical Discectomy and Fusion for Single-Level Symptomatic Cervical Disc Disease: Seven-Year Follow-up of the Prospective Randomized U.S. Food and Drug Administration Investigational Device Exemption Study.

Authors:  Michael E Janssen; Jack E Zigler; Jeffrey M Spivak; Rick B Delamarter; Bruce V Darden; Branko Kopjar
Journal:  J Bone Joint Surg Am       Date:  2015-11-04       Impact factor: 5.284

9.  Long-Term Clinical Experience with Selectively Constrained SECURE-C Cervical Artificial Disc for 1-Level Cervical Disc Disease: Results from Seven-Year Follow-Up of a Prospective, Randomized, Controlled Investigational Device Exemption Clinical Trial.

Authors:  Alexander Vaccaro; William Beutler; Walter Peppelman; Joseph Marzluff; Andrew Mugglin; Prem S Ramakrishnan; Jacqueline Myer; Kelly J Baker
Journal:  Int J Spine Surg       Date:  2018-08-15

10.  Long-term Results Comparing Cervical Disc Arthroplasty to Anterior Cervical Discectomy and Fusion: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Qiao-Li Wang; Zhi-Ming Tu; Pan Hu; Filippos Kontos; Ya-Wei Li; Lei Li; Yu-Liang Dai; Guo-Hua Lv; Bing Wang
Journal:  Orthop Surg       Date:  2019-12-21       Impact factor: 2.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.